Brief: Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results
May 15 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* ZYNERBA PHARMACEUTICALS INC - $44.4 MILLION IN CASH AND
CASH
EQUIVALENTS AT MARCH 31, 2023; CASH RUNWAY TO MID-YEAR 2024
* ZYNERBA PHARMACEUTICALS INC Q1 LOSS PER SHARE $0.21
Source text for Eikon: ID:nGNX24LFK1
Further company coverage: ZYNE.O
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary